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BACKGROUND: Attenuated auditory mismatch negativity (MMN) is a robust 
finding in schizophrenia and has been proposed as an endophenotype for the disorder. 
Glutamatergic dysfunction at the genetic and protein level has been observed in 
schizophrenia and may underlie reduced MMN. Exogenous cannabinoids such as 
delta-9-tetrahydrocannabinol (THC) modulate CB1 regulation of NMDA receptors 
and disrupt normal glutamatergic functioning. Acute administration of cannabinoids 
and NMDA receptor antagonists has been shown to modulate MMN. Cannabis is a 
known risk factor for the development of schizophrenia and psychosis in vulnerable 
individuals. Chronic exposure has been shown to lead to similar structural and 
cognitive deficits observed in schizophrenia, suggesting a common underlying 
pathology. This study aimed to investigate the effects of regular long-term cannabis 
use on MMN as a vulnerability marker of schizophrenia and psychosis. 
METHODS: Long-term heavy cannabis users (n=47) and healthy age and gender 
matched non-user controls (n=47) were compared on MMN response to duration, 
frequency and intensity deviants presented in a multi-feature paradigm. Tones were 
presented binaurally using headphones at a constant 500ms stimulus onset asynchrony 
with a 5ms rise/fall time. MMN waveforms for each condition were extracted from 
difference waveforms between the standard (50ms, 80dB, 1000Hz, 82%) and deviant 
(duration, 100ms, 6%; frequency, 1200Hz, 6%; intensity, 90dB, 6%) event related 
potentials. EEG was recorded with an initial nose reference and extracted waveforms 
were re-referenced to the average of the mastoids. Cannabis users had a mean 
frequency use of 24.37 days/month and a mean quantity use of 406.38 cones/month. 
Cannabis users remained abstinent for a minimum of 12 hours prior to testing. 
Cannabis use parameters and symptomatic measures were examined in relation to 
MMN peak amplitude and latency at the Fz electrode. 
RESULTS: Group differences showed reduced MMN peak amplitude in the cannabis 
group relative to controls for duration (F(1,78) = 35.55, p <.001) and frequency 
(F(1,80) = 9.38, p = .003) conditions. Peak amplitude for intensity MMN did not 
differ between groups. No group differences were observed for MMN peak latency 
(all F values <1). Exploratory analysis of symptomatic measures showed that 
cannabis users scored significantly higher than controls on Community Assessment of 
Psychiatric Symptoms (CAPE) total frequency scores (p = 0.01) and CAPE negative 
dimension frequency scores (p = 0.034). Cannabis users also scored higher on 
Schizotypal Personality Questionnaire (SPQ) total scores (p = 0.009) and on several 
subscale scores. None of the symptomatic measures nor any cannabis use parameters 
correlated with MMN peak amplitude in the duration or frequency condition. 
DISCUSSION: The current findings provide support for chronic cannabis use as an 
increased risk factor in the development of depressive and negative symptoms. The 
current data also provide some evidence of a glutamatergic dysfunction in regular 
long-term cannabis users, indicated by reduced MMN amplitude to frequency and 
duration deviants. Attenuated MMN to changes in duration and frequency of auditory 
stimuli is a robust finding in schizophrenia. The current findings of reduced MMN 
amplitude to duration and frequency deviants in cannabis users suggest that chronic 
cannabis use may affect early sensory information processing in a similar way to that 
observed in schizophrenia. This could potentially be explained by glutamatergic 
dysfunction as a result of prolonged exposure to cannabis and inform mechanisms by 
which cannabis could trigger psychosis. 
 
 
